Abstract:【Objective】To investigate the inhibition proliferation effect of the targeting IL18-EGF fused protein created by ourselves on human hepatic carcinoma cell lines SMMC-7721 cells in vivo and the inhibitory rate in nude mice model so as to seeking a new way for biological therapy of human hepatic carcinoma.【Methods】 SMMC-7721 cells were subcutaneously injected into the right flank of Balb/c nude mice.The mice with established SMMC-7721 xenograft were randomized into three groups of treatment:IL18-EGF,rhIL18 and NS blank group.Tu-mor-bearing mice were treated with peritumoral subcutaneously injection of NK-92 cells irradiated with X-ray fol-lowed by peritumoral subcutaneously injection of the three groups.The next morning after the last dosage,all mice were sacrificed and the tumor masses and mouse organs were completely dissected for further usage.【Results】Be-fore the end of therapy,we found volume of xenograft tumor was(0.063±0.030) mm3 in IL18-EGF group,(0.212± 0.037) mm3 in rhIL18 group,and(0.432±0.030) mm3 in control group respectively.Compared to control,SMMC-7721 xenograft growth in Balb/c nude mice was markedly inhibited with peritumoral injection of IL18-EGF or rhIL18(P <0.01).Furthermore,the inhibitory effect of IL18-EGF on SMMC-7721 growth in vivo was more profound than that of rhIL18(P <0.05).Meanwhile,more tumor cells were arrested in G1 phase in IL18-EGF group(96.11%± 1.51%),compared to rhIL18 group [(81.3%±2.02%),P <0.05] as well as to control [(72.18%±0.46%),P <0.01].The difference on the percentage of G1 phase between rhIL18 group and control was also significant(P <0.05).The per-centages of S phase in IL18-EGF group,rhIL18 group and control were(3.69%±0.41%),(16.51%±1.25%),and(23.85%±1.36%),respectively(IL18-EGF vs rhIL18:P <0.01;IL18-EGF vs control:P <0.01;IL18 vs control:P < 0.05).Tumor spontaneous apoptotic rates in IL18-EGF,rhIL18 and control group were(28.05%±3.89%)(P <0.05,compared to control),(25.48%±5.46%)(P <0.05,compared to control) and(7.10%±1.13%),respectively.And there was still not significant difference between IL18-EGF and rhIL18 group on spontaneous apoptosis induction.No sig-nificant difference was observed on pathologic features of SMMC-7721 xenograft grown in Balb/c nude mice treated with IL18-EGF,rhIL18 and control,respectively.【Conclusions】Subcutaneous injection of IL18-EGF and NK cells adjacent to tumor significantly inhibited the growth of SMMC-7721 transplantation tumor which suggested that IL18-EGF fused protein owned the effect of the antineoplastic activity in vivo and can be an effective means in the biological therapy.

Inhibition Effects on Liver Tumors of BALB/c Mice Bearing H22 Cells by Immunization with a Recombinant Immunogen of GnRH Linked to Heat Shock Protein 65.

Immunization with a recombinant GnRH vaccine conjugated to heat shock protein 65 inhibits tumor growth in orthotopic prostate cancer mouse model.

Antitumor Effect of Immunizations with Fusions of Dendritic and Hepatocellular Carcinoma Cells in Mice

Immunization with a Recombinant GnRH Vaccine Fused to Heat Shock Protein 65 Inhibits Mammary Tumor Growth in Vivo.

Antitumor therapeutic effect induced by intestine- carcinoma cells vaccine expressing membrane- bound heat shock protein 70

Antitumor Effects Of Interleukin-18 Gene-Modified Hepatocyte Cell Line On Implanted Liver Carcinoma

The Fusion Protein of Hsp65 with Tandem Repeats of Beta-Hcg Acting As A Potent Tumor Vaccine in Suppressing Hepatocarcinoma

Antitumor Effect of Immunization with Fusion of Dendritic Cells and Hepatocellular Carcinoma Cells in Mice.

[Antitumor Research on Human Laryngeal Carcinoma with Combined Application of VP3 Gene, IL-18 Gene and HN Gene].

Experimental Study of Specific Immunotherapy Induced by H22 Autologous Tumor As Whole Tumor Cell Vaccine.

[Application of a Tumor Cell Vaccine Transfected with GM-CSF/IL-2 Fusion Gene for Specific Immunotherapy of Hepatocellular Carcinoma].

Retraction Note: Inhibition of RM-1 Prostate Carcinoma and Eliciting Robust Immune Responses in the Mouse Model by Using VEGF-M 2 -Gnrh 3 -Hinge-mvp Vaccine

Vaccination with the Repeat Β-Hcg C-terminal Peptide Carried by Heat Shock Protein-65 (HSP65) for Inducing Antitumor Effects

Inhibitory effect of MUC1 gene immunization on H22 hepatocellular carcinoma growth

A Synthetic Gonadotropin-Releasing Hormone (gnrh) Vaccine for Control of Fertility and Hormone Dependent Diseases Without Any Adjuvant

Influences of low dose radiation on inhibitory effects of tumor-associated antigen peptide extract of H-22 hepatocarcinoma in mice

[Application of Fusion Gene Mgm-Csf/hil-2 to Specific Immunotherapy Induced by Hepatic Tumor Cell Vaccine].

Effect of targeting IL18-EGF fused protein on the antineoplastic activity in vivo

Induction of Effective Antitumor Immune Response by Combined Administration of Hil-18 and Ndv Hn

Prevention of Hepatocellular Carcinoma in Mice by IL-2 and B7-1 Genes Co-Transfected Liver Cancer Cell Vaccines

Experimental Study on H22 Hepatoma Transplanted Subcutaneously Treated by ~(125)I Interstitial Brachytherapy